Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | RAB9A | P51151 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677537 | 0.86 | KMT2A (0.54) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL7157422 | 0.86 | CHRM2 (0.51) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL17346621 | 0.83 | NPC1 (0.72) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL10596423 | 0.83 | NPC1 (0.72) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL15741762 | 0.82 | MEN1 (0.70) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| Phenol SCHEMBL28476395 | 0.81 | KMT2A (0.49) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL560448 | 0.80 | CYP1A2 (0.45) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL15632838 | 0.79 | MEN1 (0.54) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL11778697 | 0.77 | NPC1 (0.64) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL3443629 | 0.76 | NPC1 (0.69) | NPC1RAB9ASMN1; SMN2TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4176721-B1 | BIOCIDAL POLYMER BLENDS | LANXESS DEUTSCHLAND GMBH (DE) | 2026-01-07 | — | — | EP | claimed |
| US-20240215572-A1 | ANTIMICROBIAL PARTICLE DISPERSION | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2024-07-04 | — | — | US | claimed |
| EP-2413697-B1 | STABILISATION OF COMPOUNDS CONTAINING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-08 | — | — | EP | claimed |
| US-20170215421-A1 | BIOCIDE AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-03 | — | — | US | claimed |
| EP-2779830-B1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2017-05-17 | — | — | EP | claimed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | claimed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9296878-B2 | Fungicide formulations for plasticized PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2016-03-29 | — | — | US | claimed |
| EP-2831161-B1 | FUNGICIDE FORMULATIONS FOR PLASTICIZED PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2015-11-18 | — | — | EP | claimed |
| EP-1981629-B1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2013-10-16 | — | — | EP | claimed |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2012-12-06 | — | — | US | claimed |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2012-08-16 | — | — | US | claimed |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-26 | — | — | US | claimed |
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-12 | — | — | US | claimed |
| US-20110009268-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-13 | — | — | US | claimed |
| EP-1164850-B1 | AQUEOUS FUNGICIDE DISPERSION | AVECIA LTD (GB) | 2003-06-25 | — | — | EP | claimed |
| US-6506794-B1 | An aqueous dispersion comprising a halopropargyl compound and a partially hydrolysed polyvinyl alcohol. The aqueous dispersions are useful for inhibiting the growth of micro-organisms on or in a medium, especially an industrial | AVECIA INC. | 2003-01-14 | — | — | US | claimed |
| EP-1164850-A1 | AQUEOUS FUNGICIDE DISPERSION | Avecia Limited (GB) | 2002-01-02 | — | — | EP | claimed |
| WO-2000057702-A1 | AQUEOUS FUNGICIDE DISPERSION | AVECIA LIMITED (GB) | 2000-10-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | SLCO4C1, SLCO2B1, SLCO2A1 | NPC1 160/4885RAB9A 1581/4885SMN1; SMN2 1710/4885 |
| US-20240215572-A1 | ANTIMICROBIAL PARTICLE DISPERSION | Q6ZSR9, PAM, ACMSD | NPC1 2204/4885RAB9A 2726/4885SMN1; SMN2 3338/4885 |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | SLCO4C1, SLCO1B3, ABCC3 | NPC1 71/4885RAB9A 1482/4885SMN1; SMN2 2780/4885 |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | TPO, BRD4, SSTR3 | NPC1 1821/4885RAB9A 1300/4885SMN1; SMN2 4365/4885 |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | TPO, AZI2, NISCH | NPC1 2100/4885RAB9A 129/4885SMN1; SMN2 2630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.